Clinical applications of fibroblast activation protein‐targeted theranostics in oncologic and nononcologic disease: Current status and future directions

Abstract Quinoline‐based fibroblast activation protein (FAP) inhibitor (FAPI)‐based positron emission tomography (PET) imaging and radioligand therapy (RLT) are being investigated for use in a wide variety of diseases, and recent results have been promising. This review summarizes the current status...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Hao Fu, Wei Guo, Jingxiong Huang, Hua Wu, Haojun Chen
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Wiley 2023-12-01
Ráidu:	iRADIOLOGY
Fáttát:	FAPI‐PET FAP‐targeted radioligand therapy FAP‐targeted theranostics fibroblast activation protein radiopharmaceuticals
Liŋkkat:	https://doi.org/10.1002/ird3.46
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!